Verified Nov 2026
Other
·

Bridgewater, New Jersey
·
Since 1991
Amarin Corporation is a biopharmaceutical company headquartered in Bridgewater, New Jersey, founded in 1991, with 50–100 employees and estimated revenue of $100–250 million. It develops cardiovascular therapeutics for global markets, particularly in the United States and Europe. The company's primary product, Vascepa (icosapent ethyl), is an FDA-approved high-purity omega-3 prescription medication used to reduce cardiovascular risk in high-risk patients with elevated triglycerides.
Amarin Corporation at a glance
Revenue
$100-250M
Est. band
Employees
50-100
Founded
1991
Headquarters
Bridgewater, New Jersey
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Amarin Corporation is a biopharmaceutical company headquartered in Bridgewater, New Jersey, founded in 1991, with 50–100 employees and estimated revenue of $100–250 million. It develops cardiovascular therapeutics for global markets, particularly in the United States and Europe. The company's primary product, Vascepa (icosapent ethyl), is an FDA-approved high-purity omega-3 prescription medication used to reduce cardiovascular risk in high-risk patients with elevated triglycerides.
At a glance
Attribute | Detail |
|---|---|
Founded | 1991 |
Headquarters | Bridgewater, New Jersey |
Employees | 50-100 |
Revenue | $100-250M (estimated) |
What Amarin Corporation makes
Amarin manufactures Vascepa as a prescription omega-3 therapeutic approved by the U.S. FDA and European EMA for use as an adjunct to statin therapy and for severe hypertriglyceridemia treatment.
Products and capabilities described on the company's own site include LED, Emissions (source: amarincorp.com).
Latest developments
2026-10-28 — Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income – Amarin Corporation plc (amarincorp.com)
2026-04-29 — Amarin Reports 2026 First Quarter Financial Results – Amarin Corporation plc (amarincorp.com)
2026-02-25 — Amarin Reports Fourth Quarter and Full Year 2025 Financial Results – Amarin Corporation plc (amarincorp.com)
2026-01-08 — Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities – Amarin Corporation plc (amarincorp.com)
2025-07-30 — Amarin Reports Second Quarter 2025 Financial Results – Amarin Corporation plc (amarincorp.com)
2025-06-24 — Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe – Amarin Corporation plc (amarincorp.com)
Company details
The company operates with dual headquarters in Bridgewater, New Jersey, and Dublin, Ireland, and distributes its cardiovascular products through wholesalers and specialty pharmacies across multiple geographies. Amarin Corporation was founded in 1991, has an estimated 50-100 employees, and is headquartered in Bridgewater, New Jersey.
Frequently asked questions
What does Amarin Corporation do?
Amarin Corporation is a biopharmaceutical company headquartered in Bridgewater, New Jersey, founded in 1991, with 50–100 employees and estimated revenue of $100–250 million. It develops cardiovascular therapeutics for global markets, particularly in the United States and Europe. The company's primary product, Vascepa (icosapent ethyl), is an FDA-approved high-purity omega-3 prescription medication used to reduce cardiovascular risk in high-risk patients with elevated triglycerides.
Where is Amarin Corporation headquartered?
Amarin Corporation is headquartered in Bridgewater, New Jersey (440 U.S. 22, Bridgewater, New Jersey, 08807).
When was Amarin Corporation founded?
Amarin Corporation was founded in 1991.
How big is Amarin Corporation?
Amarin Corporation has an estimated 50-100 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
